Home > Quotes > TEVA > Company News

Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$40.23
*  
0.27
  negative  
0.68%
Get TEVA Alerts
*Delayed - data as of May 17, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Teva More Undervalued Than Mylan, Looks Towards Technology
4/18/2013 5:56:00 AM - Seeking Alpha

Teva Reports Data From Sub-analysis Of Phase III Trial Of Milprosa Vaginal Ring
4/17/2013 8:58:00 AM - RTT News

OncoGenex' OGX-427 Progresses - Analyst Blog
4/12/2013 5:08:04 PM - Zacks.com

Cramer's Mad Money - 3 Sectors That Have Not Yet Rallied (4/11/13)
4/12/2013 6:40:00 AM - Seeking Alpha

Opko's Frost Continues To Prop Up The Company's Shares
4/11/2013 5:52:00 AM - Seeking Alpha

UPDATE: Some Drug Makers Cut Payments, Meals Provided to Doctors
4/10/2013 3:39:00 PM - Dow Jones Business News

TRO on Actavis Sale of Generic Pulmicort Respules - Analyst Blog
4/10/2013 10:50:01 AM - Zacks.com

Some Drug Makers Cut Payments, Meals Provided to Doctors
4/10/2013 9:39:00 AM - Dow Jones Business News

Another Israel ETF Is On The Way
4/9/2013 3:48:00 PM - Seeking Alpha

Correction to Plan B Contraceptive Story - April 5
4/8/2013 4:23:00 PM - Dow Jones Business News

Teva-Handok Names Yoo Suk Hong CEO - Quick Facts
4/8/2013 4:05:00 AM - RTT News

Teva Appoints Ichiro Kikushige As Chief Executive Officer, Teva Seiyaku, Japan
4/8/2013 12:22:00 AM - RTT News

Can Teva's Short-Term Pressure Be Justified?
4/5/2013 3:05:00 PM - Seeking Alpha

Synthetic Biologics Says PTO Issues Patent On Estriol, Copaxone Combo For MS
4/4/2013 2:50:00 PM - RTT News

Teva's Quartette Approved in the US - Analyst Blog
4/4/2013 10:08:29 AM - Zacks.com

Evolution Of Biotech Industry: A Quick Look At Diversification, Divesting And Partnering
4/4/2013 8:15:00 AM - Seeking Alpha

Court Rules Against AstraZeneca - Analyst Blog
4/3/2013 5:22:08 PM - Zacks.com

Court Rules AstraZeneca's One Pulmicort Respules Patent In US Invalid
4/2/2013 4:23:00 AM - RTT News

Court Rules AstraZeneca's U.S. Pulmicort Patent Invalid
4/2/2013 3:59:00 AM - Dow Jones Business News

10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March
4/1/2013 9:42:00 AM - Seeking Alpha

FDA Approves Teva's New Drug Application For Oral Contraceptive Quartette
3/29/2013 9:10:00 AM - RTT News

FDA Approves Teva Pharma's NDA For Quartette Contraceptives - Quick Facts
3/29/2013 8:13:00 AM - RTT News

Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy
3/28/2013 9:14:00 AM - Seeking Alpha

2ND UPDATE: FDA Approves Biogen's Pill to Treat Multiple Sclerosis
3/27/2013 7:02:00 PM - Dow Jones Business News

Correction to Stories About FDA's Approval of Biogen's MS Pill
3/27/2013 6:45:00 PM - Dow Jones Business News